Vernalis expands frovatriptan collaboration with Elan; company to buy out royalties from SB Dec. 29, 2000
Arylamidines and cyclic amidines with broad clinical application reported by Merck & Co. Dec. 28, 2000
Competitive metabotropic glutamate receptor antagonist with some selectivity for mglu5 subtype Dec. 28, 2000